310 related articles for article (PubMed ID: 8747958)
1. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
[TBL] [Abstract][Full Text] [Related]
2. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
[TBL] [Abstract][Full Text] [Related]
3. Effects of trapidil and suramin on growth factor-induced calcium response and tyrosine phosphorylation in human glioma cells.
Bando K; Kannuki S; Rokutan K; Shouno M; Matsumoto K
Neurol Med Chir (Tokyo); 1995 Sep; 35(9):631-8. PubMed ID: 7566395
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain.
Penar PL; Khoshyomn S; Bhushan A; Tritton TR
Neurosurgery; 1997 Jan; 40(1):141-51. PubMed ID: 8971836
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells.
Kaufmann K; Thiel G
J Neurol Sci; 2001 Aug; 189(1-2):83-91. PubMed ID: 11535237
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
9. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.
Peterson G; Barnes S
Prostate; 1993; 22(4):335-45. PubMed ID: 8497428
[TBL] [Abstract][Full Text] [Related]
10. P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.
Milenkovic I; Weick M; Wiedemann P; Reichenbach A; Bringmann A
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1211-20. PubMed ID: 12601051
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells.
Piontek M; Hengels KJ; Porschen R; Strohmeyer G
Anticancer Res; 1993; 13(6A):2119-23. PubMed ID: 8297123
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro.
Twaddle GM; Turbov J; Liu N; Murthy S
J Surg Oncol; 1999 Feb; 70(2):83-90. PubMed ID: 10084649
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
Klein JM; McCarthy TA
Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
[TBL] [Abstract][Full Text] [Related]
15. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
[TBL] [Abstract][Full Text] [Related]
16. Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways.
Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
J Neurosurg; 1991 Aug; 75(2):284-93. PubMed ID: 1649272
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway.
Baltuch GH; Yong VW
Brain Res; 1996 Feb; 710(1-2):143-9. PubMed ID: 8963653
[TBL] [Abstract][Full Text] [Related]
19. Effect of tyrosine kinase inhibition on basal and epidermal growth factor-stimulated human Caco-2 enterocyte sheet migration and proliferation.
Basson MD; Beidler DR; Turowski G; Zarif A; Modlin IM; Jena BP; Madri JA
J Cell Physiol; 1994 Sep; 160(3):491-501. PubMed ID: 8077287
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between receptors with intrinsic tyrosine kinase activity and alpha1b-adrenoceptors.
del Carmen Medina L; Vázquez-Prado J; García-Sáinz JA
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):413-9. PubMed ID: 10947955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
